This week on Contemporary OB/GYN: Nov. 22 to Nov. 26
Here's what's coming up this week on Contemporary OB/GYN.
Large portion of hospital personnel still unvaccinated against COVID-19
Nearly a third of hospital personnel had still not been vaccinated against COVID-19 by mid-September.
The future of pelvic floor surgery
"We're moving from an era where it was all based on judgment, and experience, to an era where treatments will be based on firm evidence of the structural failures present in each patient," says Contemporary OB/GYN Advisory Board member John O. L. DeLancey, MD.
City of Hope Opens Oncolytic Virus Clinical Trial for Patients with Advanced Breast Cancer
The trial is the first in the world offering this City of Hope-developed investigational therapy to patients with the hope of one day improving survival for people with triple-negative breast cancer.
Disparities in kidney care access for pregnant patients
December 11th 2023A recent study highlights significant disparities in kidney transplant and nephrology care access for pregnant patients with end-stage kidney disease, revealing reduced survival rates and limited access to crucial care compared to non-pregnancy-related causes.
Read More
Mediterranean diet linked to improved pregnancy outcomes
December 8th 2023A comprehensive meta-analysis scrutinizes the Mediterranean diet's impact on female reproductive health, uncovering compelling evidence that links this nutritional approach to a significant reduction in adverse pregnancy outcomes.
Read More
FDA grants IND clearance to DARE-VVA1 for dyspareunia
December 7th 2023Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Read More
